Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

1-Meth-oxy-4-({[(4-meth-oxy-phen-yl)-sulfan-yl](phen-yl)meth-yl}sulfan-yl)benzene.

ABSTRACT: The title compound, C(21)H(20)O(2)S(2), forms a propeller-shaped structure with the tetra-hedral C atom as the central hub and meth-oxy-benzene and phenyl residues as radiating blades. Short C-H?? contacts are observed.

SUBMITTER: Li H

PROVIDER: S-EPMC3297852 | biostudies-other | 2012 Mar

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Publications

1-Meth-oxy-4-({[(4-meth-oxy-phen-yl)-sulfan-yl](phen-yl)meth-yl}sulfan-yl)benzene.

Li Hongqi H Ramachandran G G Sathishkumar M M Sathiyanarayanan K K Rathore R S RS

Acta crystallographica. Section E, Structure reports online 20120217 Pt 3

The title compound, C(21)H(20)O(2)S(2), forms a propeller-shaped structure with the tetra-hedral C atom as the central hub and meth-oxy-benzene and phenyl residues as radiating blades. Short C-H⋯π contacts are observed. ...[more]

PMID: 22412655

Similar Datasets

N-(4-Meth-oxy-phen-yl)benzene-sulfonamide.

Project description:In the title compound, C(13)H(13)NO(3)S, the benzene ring of the benzene-sulfonamide moiety is disordered with an occupancy ratio of 0.56 (3):0.44 (3), the disorder components being twisted at and angle of 21 (1)° to each other. The meth-oxy-benzene group is roughly planar (r.m.s. deviation = 0.0144 Å) and the amide N atom is displaced from this plane by 0.090 (6) Å. The dihedral angles between the meth-oxy-benzene group and the major and minor occupancy components of the disordered benzene ring are 54.6 (4) and 62.9 (5)°, respectively. In the crystal, infinite polymeric chains are formed along [100] due to inter-molecular N-H⋯O hydrogen bonding. Weak C-H⋯π inter-actions are also present in the crystal.

| S-EPMC3051711 | biostudies-literature

Crystal structure of 2-meth-oxy-2-[(4-meth-oxy-phen-yl)sulfan-yl]-1-phenyl-ethanone.

Project description:In the title β-thio-carbonyl compound, C16H16O3S, the adjacent meth-oxy and carbonyl O atoms are synperiplanar [the O-C-C-O torsion angle is 19.8 (4)°] and are separated by 2.582 (3) Å. The dihedral angle between the rings is 40.11 (16)°, and the meth-oxy group is coplanar with the benzene ring to which it is connected [the C-C-O-C torsion angle is 179.1 (3)°]. The most notable feature of the crystal packing is the formation of methine and methyl C-H⋯O(carbon-yl) inter-actions that lead to a supra-molecular chain with a zigzag topology along the c axis. Chains pack with no specific inter-molecular inter-actions between them.

| S-EPMC4555440 | biostudies-literature

N-(2-{[5-Bromo-2-(morpholin-4-yl)pyrimidin-4-yl]sulfan-yl}-4-meth-oxy-phen-yl)-4-methyl-benzene-sulfonamide.

Project description:In the title compound, C(22)H(23)BrN(4)O(4)S(2), the benzene rings bridged by the sulfonamide group are tilted relative to each other by 68.9?(1)° and the dihedral angle between the sulfur-bridged pyrimidine and benzene rings is 69.7?(1)°. The mol-ecular conformation is stabilized by a weak intra-molecular ?-? stacking inter-action between the pyrimidine and the 4-methylbenzene rings [centroid-centroid distance = 3.934?(2)?Å]. The morpholine ring adopts a chair conformation and is disordered over two positions with an occupancy ratio of 0.853?(6):0.147?(6). In the crystal, mol-ecules are linked by N-H?O hydrogen bonds into chains extending along the a axis and further, through C-H?N and C-H?O inter-actions, into a three-dimensional supramolecular structure.

| S-EPMC3415028 | biostudies-literature

N-(2-{[5-Bromo-2-(piperidin-1-yl)pyrimidin-4-yl]sulfan-yl}-4-meth-oxy-phen-yl)-2,4,6-trimethyl-benzene-sulfonamide.

Project description:In the title compound, C(25)H(29)BrN(4)O(3)S(2), the benzene rings bridged by the sulfonamide group are tilted relative to each other by 63.9 (1)° and the dihedral angle between the sulfur-bridged pyrimidine and benzene rings is 64.9 (1)°. The mol-ecular conformation is stabilized by a weak intra-molecular π-π stacking inter-action between the pyrimidine and the 2,4,6-trimethyl-benzene rings [centroid-centroid distance = 3.766 (2) Å]. The piperidine ring adopts a chair conformation. In the crystal, mol-ecules are linked into inversion dimers by pairs of N-H⋯O hydrogen bonds and these dimers are further linked by C-H⋯O hydrogen bonds into chains propagating along [010].

| S-EPMC3435802 | biostudies-literature

N-(2-{[5-Bromo-2-(morpholin-4-yl)pyrimidin-4-yl]sulfan-yl}-4-meth-oxy-phen-yl)-4-chloro-benzene-sulfonamide.

Project description:In the title compound, C(21)H(20)BrClN(4)O(4)S(2), the benzene rings bridged by the sulfonamide group are tilted relative to each other by a dihedral angle of 70.2 (1)° and the dihedral angle between the sulfur-bridged pyrimidine and benzene rings is 69.5 (1)°. The mol-ecular conformation is stabilized by a weak intra-molecular π-π stacking inter-action between the pyrimidine and the 4-chloro-benzene rings [centroid-centroid distance = 3.978 (2) Å]. The morpholine ring adopts a chair conformation. In the crystal, mol-ecules are linked into inversion dimers by pairs of C-H⋯N hydrogen bonds and these dimers are further connected by N-H⋯O hydrogen bonds, forming a tape along the a axis.

| S-EPMC3435827 | biostudies-literature

N-(2-Formyl-phen-yl)-4-meth-oxy-N-(4-meth-oxy-phenyl-sulfon-yl)benzene-sulfonamide.

Project description:In the title compound, C(21)H(19)NO(7)S(2), the dihedral angles between the formyl-phenyl ring and the two meth-oxy-phenyl rings are 33.87 (9) and 41.00 (10)°. The S atoms have a distorted tetra-hedral geometry and the N atom shows a trigonally planar [r.m.s. deviation = 0.0437 (13) Å] coordination. The crystal structure is stabilized by inter-molecular C-H⋯O hydrogen bonds.

| S-EPMC3238957 | biostudies-literature

N-(4-Meth-oxy-phen-yl)-4-methyl-benzene-sulfonamide.

Project description:In the title compound, C(14)H(15)NO(3)S, the dihedral angle between the aromatic rings is 59.39?(14)° and the C-S-N-C torsion angle is -71.4?(2)°. In the crystal, a supra-molecular chain running along the b axis with a C(4) graph set is formed via N-H?O hydrogen bonds.

| S-EPMC3050146 | biostudies-literature

N-(5-Chloro-2-meth-oxy-phen-yl)benzene-sulfonamide.

Project description:In the title compound, C(13)H(12)ClNO(3)S, the dihedral angle between the two aromatic rings is 73.94?(9)°. An intra-molecular C-H?O hydrogen bond occurs. In the crystal, inter-molecular N-H?O hydrogen bonds connect the mol-ecules to centrosymmetric dimers, forming an R(2) (2)(8) ring motif. The packing is consolidated by C-H?O hydrogen bonds and weak ?-? inter-actions [centroid-centroid distances = 3.81?(3) and 3.81?(3)?Å].

| S-EPMC3009279 | biostudies-literature

N-(2-Meth-oxy-phen-yl)-4-methyl-benzene-sulfonamide.

Project description:In the title compound, C(14)H(15)NO(3)S, the geometry around the S atom of the SO(2) group is distorted tetra-hedral. The meth-oxy- and methyl-substituted aromatic rings are oriented at a dihedral angle of 71.39?(9)°. Inter-molecular N-H?O hydrogen bonds form inversion dimers, which stabilize the crystal structure.

| S-EPMC3009290 | biostudies-literature

N-(4-Acetyl-phen-yl)-4-meth-oxy-benzene-sulfonamide.

Project description:The title compound, C15H15NO4S, was obtained by the condensation of 4-amino-aceto-phenone and 4-meth-oxy-benzene-sulfonyl chloride. The dihedral angle between the benzene rings is 86.56?(9)° and the mol-ecule has an approximate V-shaped conformation. The C atom of the meth-oxy group is roughly coplanar with its attached ring [deviation = 0.177?(3)?Å], as is the methyl C atom of the acetyl group with its ring [deviation = 0.065?(2)?Å]. An intra-molecular C-H?O inter-action generates an S(6) ring. In the crystal, N-H?O and C-H?O hydrogen bonds link the mol-ecules into [010] chains. Weak C-H?? inter-actions are also observed.

| S-EPMC3885030 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data